NASDAQ:XXII 22nd Century Group (XXII) Stock Price, News & Analysis $0.60 -0.01 (-1.84%) Closing price 04:00 PM EasternExtended Trading$0.60 0.00 (-0.63%) As of 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About 22nd Century Group Stock (NASDAQ:XXII) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get 22nd Century Group alerts:Sign Up Key Stats Today's Range$0.57▼$0.6250-Day Range$0.58▼$3.9352-Week Range$0.51▼$358.80Volume166,514 shsAverage Volume858,879 shsMarket Capitalization$2.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview 22nd Century Group, Inc., founded in 1998 and headquartered in New York, is a plant biotechnology company that applies proprietary breeding and gene modulation technologies to tobacco, hemp and related plant species. The company’s core mission is to develop and commercialize plant-based solutions that address public health, consumer wellness and agronomic needs. Its flagship reduced nicotine tobacco platform is engineered to deliver significantly lower levels of nicotine than conventional tobacco products while retaining the sensory characteristics sought by adult smokers. Through its branded reduced nicotine tobacco products, marketed under the NEXT Generation™ portfolio, and its GenCanna® subsidiary focused on hemp cultivation and cannabinoid extraction, 22nd Century serves both commercial markets and contract research clients. GenCanna produces and distributes hemp-derived phytocannabinoids—including cannabidiol (CBD)—in bulk and finished-goods formats for nutraceutical, wellness and personal care manufacturers across North America and select international markets. The company’s integrated value chain encompasses seed development, greenhouse propagation, analytical testing and large-scale processing. In addition to product commercialization, 22nd Century offers contract research and development services that leverage its greenhouse, field and laboratory facilities. Its R&D capabilities support trait discovery, regulatory compliance testing and pilot-scale production, enabling partnerships with government agencies, clinical researchers and industry stakeholders. With research centers in New York and North Carolina, the company pursues ongoing collaborations aimed at advancing low-nicotine tobacco science and expanding plant-based cannabinoid applications globally.AI Generated. May Contain Errors. Read More 22nd Century Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreXXII MarketRank™: 22nd Century Group scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus Rating22nd Century Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst Coverage22nd Century Group has only been the subject of 1 research reports in the past 90 days.Read more about 22nd Century Group's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of 22nd Century Group is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 22nd Century Group is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratio22nd Century Group has a P/B Ratio of 0.13. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted19.74% of the float of 22nd Century Group has been sold short.Short Interest Ratio / Days to Cover22nd Century Group has a short interest ratio ("days to cover") of 0.95, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in 22nd Century Group has recently increased by 19.94%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend Yield22nd Century Group does not currently pay a dividend.Dividend Growth22nd Century Group does not have a long track record of dividend growth. News and Social Media3.4 / 5News Sentiment0.50 News Sentiment22nd Century Group has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 4 news articles for 22nd Century Group this week, compared to 3 articles on an average week.Search Interest3 people have searched for XXII on MarketBeat in the last 30 days. MarketBeat Follows3 people have added 22nd Century Group to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, 22nd Century Group insiders have not sold or bought any company stock.Percentage Held by Insiders0.01% of the stock of 22nd Century Group is held by insiders.Percentage Held by Institutions18.06% of the stock of 22nd Century Group is held by institutions.Read more about 22nd Century Group's insider trading history. Receive XXII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XXII Stock News Headlines22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine CigarettesMay 21 at 7:00 AM | globenewswire.com22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. RetailersMay 18 at 9:00 AM | globenewswire.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.May 21 at 1:00 AM | Profits Run (Ad)22nd Century Group Expands Distribution of VLN® Cigarettes to 150 New Locations in Metro New York and Northern New JerseyMay 15, 2026 | quiverquant.comQ22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle BrandMay 15, 2026 | globenewswire.com22nd Century Group, Inc. (NASDAQ:XXII) Q1 2026 Earnings Call TranscriptMay 13, 2026 | insidermonkey.com22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific ReviewMay 12, 2026 | globenewswire.com22nd Century Group, Inc. (XXII) Q1 2026 Earnings Call Prepared Remarks TranscriptMay 9, 2026 | seekingalpha.comSee More Headlines XXII Stock Analysis - Frequently Asked Questions How have XXII shares performed this year? 22nd Century Group's stock was trading at $11.55 at the beginning of 2026. Since then, XXII shares have decreased by 94.8% and is now trading at $0.5988. How were 22nd Century Group's earnings last quarter? 22nd Century Group, Inc (NASDAQ:XXII) released its quarterly earnings data on Thursday, May, 7th. The biotechnology company reported ($5.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.20) by $3.87. The biotechnology company had revenue of $4.11 million for the quarter, compared to the consensus estimate of $4.61 million. 22nd Century Group had a negative net margin of 25.34% and a negative trailing twelve-month return on equity of 84.37%. Read the conference call transcript. When did 22nd Century Group's stock split? 22nd Century Group shares reverse split before market open on Tuesday, December 17th 2024.The 1-135 reverse split was announced on Friday, December 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 16th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. How do I buy shares of 22nd Century Group? Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of 22nd Century Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that 22nd Century Group investors own include NVIDIA (NVDA), Meta Platforms (META), Canopy Growth (CGC), Advanced Micro Devices (AMD), Micron Technology (MU) and Novavax (NVAX). Company Calendar Last Earnings5/07/2026Today5/21/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (49m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 XXII's financial health is in the Red zone, according to TradeSmith. XXII has been in this zone for over 49 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry TOBACCO Sub-IndustryCannabis Current SymbolNASDAQ:XXII Previous SymbolAMEX:XXII CIK1347858 Webwww.xxiicentury.com Phone(716) 270-1523Fax716-877-3064Employees80Year Founded1998Profitability EPS (Trailing Twelve Months)($218.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.05 million Net Margins-25.34% Pretax Margin-81.91% Return on Equity-84.37% Return on Assets-45.90% Debt Debt-to-Equity Ratio0.02 Current Ratio2.67 Quick Ratio2.12 Sales & Book Value Annual Sales$17.59 million Price / Sales0.15 Cash FlowN/A Price / Cash FlowN/A Book Value$4.76 per share Price / Book0.13Miscellaneous Outstanding Shares4,460,000Free Float4,456,000Market Cap$2.67 million OptionableNo Data Beta0.77 Social Links Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:XXII) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 22nd Century Group, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share 22nd Century Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
